A Detailed Analysis of the Hadron Therapy Market Based on Growing Technological Advancements, New Product Launches and Increasing Incidence of Cancer
Report ID: PMRREP33914
Number of Pages: 187
Format: PPT*, PDF, EXCEL
Industry: Healthcare
Published Date: January-2024
1. Executive Summary
1.1. Global Hadron Therapy Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Type Lifecycle Analysis
2.4. Hadron Therapy Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Application Landscape
3. Global Hadron Therapy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Hadron Therapy Market Outlook: Type
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Type, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
3.3.3.1. Electron Beam
3.3.3.2. Proton Beam
3.3.3.3. Neutron Beam
3.3.3.4. Carbon Ion Beam
3.3.3.5. Alpha Particle Beam
3.3.3.6. Beta Particle Beam
3.4. Market Attractiveness Analysis: Type
3.5. Global Hadron Therapy Market Outlook: Application
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
3.5.3.1. For Pediatric Cancer
3.5.3.2. For Bone & Soft Tissue Cancer
3.5.3.3. For Prostate Cancer
3.5.3.4. For Lung Cancer
3.5.3.5. For Liver Cancer
3.5.3.6. For Eye Cancer
3.5.3.7. For Head & Neck Cancer
3.6. Market Attractiveness Analysis: Application
3.7. Global Hadron Therapy Market Outlook: End User
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
3.7.3.1. In Hospitals
3.7.3.2. In Government Universities
3.7.3.3. In Research Institutions
3.8. Market Attractiveness Analysis: End User
4. Global Hadron Therapy Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Hadron Therapy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Type
5.3.3. By Application
5.3.4. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
5.5.1. Electron Beam
5.5.2. Proton Beam
5.5.3. Neutron Beam
5.5.4. Carbon Ion Beam
5.5.5. Alpha Particle Beam
5.5.6. Beta Particle Beam
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
5.6.1. For Pediatric Cancer
5.6.2. For Bone & Soft Tissue Cancer
5.6.3. For Prostate Cancer
5.6.4. For Lung Cancer
5.6.5. For Liver Cancer
5.6.6. For Eye Cancer
5.6.7. For Head & Neck Cancer
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
5.7.1. In Hospitals
5.7.2. In Government Universities
5.7.3. In Research Institutions
5.8. Market Attractiveness Analysis
6. Europe Hadron Therapy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Type
6.3.3. By Application
6.3.4. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Türkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
6.5.1. Electron Beam
6.5.2. Proton Beam
6.5.3. Neutron Beam
6.5.4. Carbon Ion Beam
6.5.5. Alpha Particle Beam
6.5.6. Beta Particle Beam
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
6.6.1. For Pediatric Cancer
6.6.2. For Bone & Soft Tissue Cancer
6.6.3. For Prostate Cancer
6.6.4. For Lung Cancer
6.6.5. For Liver Cancer
6.6.6. For Eye Cancer
6.6.7. For Head & Neck Cancer
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
6.7.1. In Hospitals
6.7.2. In Government Universities
6.7.3. In Research Institutions
6.8. Market Attractiveness Analysis
7. East Asia Hadron Therapy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Type
7.3.3. By Application
7.3.4. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
7.5.1. Electron Beam
7.5.2. Proton Beam
7.5.3. Neutron Beam
7.5.4. Carbon Ion Beam
7.5.5. Alpha Particle Beam
7.5.6. Beta Particle Beam
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
7.6.1. For Pediatric Cancer
7.6.2. For Bone & Soft Tissue Cancer
7.6.3. For Prostate Cancer
7.6.4. For Lung Cancer
7.6.5. For Liver Cancer
7.6.6. For Eye Cancer
7.6.7. For Head & Neck Cancer
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
7.7.1. In Hospitals
7.7.2. In Government Universities
7.7.3. In Research Institutions
7.8. Market Attractiveness Analysis
8. South Asia & Oceania Hadron Therapy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Type
8.3.3. By Application
8.3.4. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
8.5.1. Electron Beam
8.5.2. Proton Beam
8.5.3. Neutron Beam
8.5.4. Carbon Ion Beam
8.5.5. Alpha Particle Beam
8.5.6. Beta Particle Beam
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
8.6.1. For Pediatric Cancer
8.6.2. For Bone & Soft Tissue Cancer
8.6.3. For Prostate Cancer
8.6.4. For Lung Cancer
8.6.5. For Liver Cancer
8.6.6. For Eye Cancer
8.6.7. For Head & Neck Cancer
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
8.7.1. In Hospitals
8.7.2. In Government Universities
8.7.3. In Research Institutions
8.8. Market Attractiveness Analysis
9. Latin America Hadron Therapy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Type
9.3.3. By Application
9.3.4. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
9.5.1. Electron Beam
9.5.2. Proton Beam
9.5.3. Neutron Beam
9.5.4. Carbon Ion Beam
9.5.5. Alpha Particle Beam
9.5.6. Beta Particle Beam
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
9.6.1. For Pediatric Cancer
9.6.2. For Bone & Soft Tissue Cancer
9.6.3. For Prostate Cancer
9.6.4. For Lung Cancer
9.6.5. For Liver Cancer
9.6.6. For Eye Cancer
9.6.7. For Head & Neck Cancer
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
9.7.1. In Hospitals
9.7.2. In Government Universities
9.7.3. In Research Institutions
9.8. Market Attractiveness Analysis
10. Middle East & Africa Hadron Therapy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Type
10.3.3. By Application
10.3.4. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
10.5.1. Electron Beam
10.5.2. Proton Beam
10.5.3. Neutron Beam
10.5.4. Carbon Ion Beam
10.5.5. Alpha Particle Beam
10.5.6. Beta Particle Beam
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
10.6.1. For Pediatric Cancer
10.6.2. For Bone & Soft Tissue Cancer
10.6.3. For Prostate Cancer
10.6.4. For Lung Cancer
10.6.5. For Liver Cancer
10.6.6. For Eye Cancer
10.6.7. For Head & Neck Cancer
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
10.7.1. In Hospitals
10.7.2. In Government Universities
10.7.3. In Research Institutions
10.8. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Electron Beam
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Koninklijke Philips N.V.
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. IBA Worldwide
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Advanced Oncotherapy
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Varian Medical Systems, Inc.
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Optivus Proton Therapy, Inc.
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Hitachi, Ltd.
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Sumitomo Corporation
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Mevion Medical Systems
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. ProNova Solutions, LLC
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. ProTom International Mitsubishi Electric Corporation
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. Elekta
11.3.11.1. Overview
11.3.11.2. Segments and Product
11.3.11.3. Key Financials
11.3.11.4. Market Developments
11.3.11.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations